<i>Dyrk1a</i> from Gene Function in Development and Physiology to Dosage Correction across Life Span in Down Syndrome
Down syndrome is the main cause of intellectual disabilities with a large set of comorbidities from developmental origins but also that appeared across life span. Investigation of the genetic overdosage found in Down syndrome, due to the trisomy of human chromosome 21, has pointed to one main driver...
Guardado en:
Autores principales: | Helin Atas-Ozcan, Véronique Brault, Arnaud Duchon, Yann Herault |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b119098bae63424dbbd3a1627c889041 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Adalimumab Therapy in a Patient with Psoriasis, Down Syndrome, and Concomitant Hepatitis B Virus Infection
por: Madani A, et al.
Publicado: (2021) -
FREQUENCY OF CLINICAL FEATURES AND CYTOGENETIC DEFECTS IN DOWN SYNDROME DIAGNOSED AT AFIP
por: Saira Irum, et al.
Publicado: (2021) -
Ten Reasons Why People With Down Syndrome are Protected From the Development of Most Solid Tumors -A Review
por: Marta Pilar Osuna-Marco, et al.
Publicado: (2021) -
Treatment Considerations for Obstructive Sleep Apnea in Pediatric Down Syndrome
por: Erica Gastelum, et al.
Publicado: (2021) -
β-Dystroglycan Restoration and Pathology Progression in the Dystrophic <i>mdx</i> Mouse: Outcome and Implication of a Clinically Oriented Study with a Novel Oral Dasatinib Formulation
por: Paola Mantuano, et al.
Publicado: (2021)